KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Research & Development (2016 - 2025)

Historic Research & Development for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $2.6 billion.

  • Bristol Myers Squibb's Research & Development fell 1895.96% to $2.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.0 billion, marking a year-over-year decrease of 1082.53%. This contributed to the annual value of $10.0 billion for FY2025, which is 1082.53% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Research & Development stood at $2.6 billion, which was down 1895.96% from $2.5 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Research & Development's 5-year high stood at $3.2 billion during Q4 2024, with a 5-year trough of $2.2 billion in Q1 2021.
  • In the last 5 years, Bristol Myers Squibb's Research & Development had a median value of $2.5 billion in 2021 and averaged $2.5 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Research & Development soared by 2877.32% in 2024 and then tumbled by 1895.96% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Research & Development (Quarter) stood at $2.5 billion in 2021, then dropped by 0.32% to $2.5 billion in 2022, then fell by 1.27% to $2.5 billion in 2023, then increased by 28.77% to $3.2 billion in 2024, then dropped by 18.96% to $2.6 billion in 2025.
  • Its Research & Development stands at $2.6 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.6 billion for Q2 2025.